Sheri Glaub

Sheri Glaub has over 25 years of experience in the pharmaceutical industry. Sheri began their career in 1993 as a Postdoctoral Research Associate at NREL. Sheri then moved to Bayer in 1995 as a Scientist. In 1997, they joined Geneva Pharmaceuticals (now Sandoz) as a Scientist III/Manager. In 1999, they became the Manager of Analytical Research and Development at Rosemont Pharmaceuticals. In 2001, they joined FeRx as a Scientist/Sr. Manager. In 2004, they were appointed Director at Tapestry Pharmaceuticals. Sheri then started their own consulting business, Glaub Consulting Services, in 2005. Since 2010, they have been a Sr. Consultant at RMC Pharmaceutical Solutions, leading analytical method development and validation projects for biopharmaceuticals and oligonucleotides. Sheri has also provided Analytical Development, Quality Control and QMS support for a Japanese client's commercial and clinical trial material biosimilar and MSC programs.

Sheri Glaub obtained their Ph.D. in Chemistry from Texas A&M University between 1988 and 1993. Prior to that, they earned a B.S. in Chemistry from the University of Illinois Urbana-Champaign.